Prevalence of Myocardial Infarction Polymorphisms in Afyonkarahisar, Western Turkey

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2012 Jul 4

PMID 22752805

Citations 13

Authors

Serap Tutgun Onrat

Onder Akci

Zafer Soylemez

Ersel Onrat

Alaettin Avsar

Affiliations

Soon will be listed here.

Abstract

The aim of the study was to investigate relationship between polymorphisms in genes that are clinical and environmental features and the risk of myocardial infarction (MI) in Afyonkarahisar subjects living in Turkey. Prevalence of the several genes polymorphisms, ≤45 (42.04 ± 3.3) and ≥46 (57.19 ± 7.5) years were studied in individuals with MI and without MI (40.30 ± 9.01) individuals were studied. We tested 140 with MI individuals for factor V (FV) Leiden, FV H1299R, Prothrombin G20210A, factor XIII (FXIII) V34L, β-fibrinogen b-455G/A, plasminogen activator inhibitor-1 (PAI-1)-675 4G/5G, human platelet antigens 1 (HPA-1) a/b, apolipoprotein B (ApoB) R3500Q, apolipoprotein E (ApoE), E2, E3, and E4, angiotensin-converting enzyme (ACE) D/I, 5,10 methylenetetrahydrofolate reductase (MTHFR) 677C/T, and MTHFR 1298A/C polymorphisms using a ViennaLab CVD strip assay. This study results were compared without MI control groups. According to the our results, prothrombin, factor XIII and MTHFRC677T deletions were the most frequent genetic variants in risk groups of hyperlipidemic patients (value of odds ratio sequentially [OR] = 4.5, p = 0.05, [OR] = 2.16, p = 0.04 and [OR] = 2.8, p = 0.09). MTHFRA1298C and PAI-1 deletions were most frequent genetic variants in risk groups for MI in patients with diabetes mellitus (value of odds ratio sequentially [OR] = 3.79, p = 0.06 and [OR] = 5 × 10(8), p = 0.000). ACE deletions were positively associated with family history of cardiovascular events (OR = 3.62, p = 0.03). We found a strong relationship between genetic variants and risk factors. Significant associations between genetic variants predicting cardiovascular events and common risk factors (hyperlipidemia, smoking, diabetes mellitus and family history) patients were found.

Citing Articles

Acute Myocardial Infarction in Patients with Hereditary Thrombophilia-A Focus on Factor V Leiden and Prothrombin G20210A.

Badescu M, Butnariu L, Costache A, Gheorghe L, Seritean Isac P, Chetran A Life (Basel). 2023; 13(6).

PMID: 37374153 PMC: 10300874. DOI: 10.3390/life13061371.

Impact of vitamin D receptor gene polymorphisms (TaqI and BsmI) on the incidence and severity of coronary artery disease: a report from southern Iran.

Akhlaghi B, Firouzabadi N, Foroughinia F, Nikparvar M, Dehghani P BMC Cardiovasc Disord. 2023; 23(1):113.

PMID: 36882686 PMC: 9993610. DOI: 10.1186/s12872-023-03155-5.

Biochemical Association of MTHFR C677T Polymorphism with Myocardial Infarction in the Presence of Diabetes Mellitus as a Risk Factor.

Mallhi T, Shahid M, Rehman K, Khan Y, Alanazi A, Alotaibi N Metabolites. 2023; 13(2).

PMID: 36837870 PMC: 9958922. DOI: 10.3390/metabo13020251.

Meta-analysis of the association between Apolipoprotein E polymorphism and risks of myocardial infarction.

Shao A, Shi J, Liang Z, Pan L, Zhu W, Liu S BMC Cardiovasc Disord. 2022; 22(1):126.

PMID: 35331149 PMC: 8952226. DOI: 10.1186/s12872-022-02566-0.

Plasminogen Activator Inhibitor-1 Polymorphisms and Risk of Coronary Artery Disease: Evidence From Meta-Analysis and Trial Sequential Analysis.

Tabaei S, Omraninava M, Mehranfar S, Motallebnezhad M, Samaneh Tabaee S Biochem Genet. 2022; 60(5):1409-1445.

PMID: 35039979 DOI: 10.1007/s10528-021-10143-x.

References

Lyon C, Hsueh W . Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease. Am J Med. 2003; 115 Suppl 8A:62S-68S. DOI: 10.1016/j.amjmed.2003.08.014. View

Franco R, Reitsma P, Lourenco D, Maffei F, Morelli V, Tavella M . Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis. Thromb Haemost. 1999; 81(5):676-9. View

Loukola A, Broms U, Maunu H, Widen E, Heikkila K, Siivola M . Linkage of nicotine dependence and smoking behavior on 10q, 7q and 11p in twins with homogeneous genetic background. Pharmacogenomics J. 2007; 8(3):209-19. DOI: 10.1038/sj.tpj.6500464. View

Ye Z, Liu E, Higgins J, Keavney B, Lowe G, Collins R . Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet. 2006; 367(9511):651-8. DOI: 10.1016/S0140-6736(06)68263-9. View

Eriksson P, Kallin B, van t Hooft F, Bavenholm P, Hamsten A . Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A. 1995; 92(6):1851-5. PMC: 42380. DOI: 10.1073/pnas.92.6.1851. View

Wolf P, DAgostino R, Kannel W, Bonita R, Belanger A . Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA. 1988; 259(7):1025-9. View

McCORMACK L, Kain K, Catto A, Kohler H, Stickland M, Grant P . Prevalence of FXIII V34L in populations with different cardiovascular risk. Thromb Haemost. 1998; 80(3):523-4. View

Prescott E, Hippe M, Schnohr P, Hein H, Vestbo J . Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ. 1998; 316(7137):1043-7. PMC: 28505. DOI: 10.1136/bmj.316.7137.1043. View

Voetsch B, Loscalzo J . Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol. 2003; 24(2):216-29. DOI: 10.1161/01.ATV.0000107402.79771.fc. View

10.

Hamsten A, de Faire U, Walldius G, Dahlen G, Szamosi A, Landou C . Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987; 2(8549):3-9. DOI: 10.1016/s0140-6736(87)93050-9. View

11.

Rosenberg R, Aird W . Vascular-bed--specific hemostasis and hypercoagulable states. N Engl J Med. 1999; 340(20):1555-64. DOI: 10.1056/NEJM199905203402007. View

12.

Dawson S, Wiman B, Hamsten A, Green F, Humphries S, Henney A . The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem. 1993; 268(15):10739-45. View

13.

Ardissino D, Mannucci P, Merlini P, Duca F, Fetiveau R, Tagliabue L . Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood. 1999; 94(1):46-51. View

14.

Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y . Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation. 1997; 95(8):2032-6. DOI: 10.1161/01.cir.95.8.2032. View

15.

Wang Q . Molecular genetics of coronary artery disease. Curr Opin Cardiol. 2005; 20(3):182-8. PMC: 1579824. DOI: 10.1097/01.hco.0000160373.77190.f1. View

16.

Vulin A, Stanley F . Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription. J Biol Chem. 2004; 279(24):25172-8. DOI: 10.1074/jbc.M403184200. View

17.

Shinozaki K, Ayajiki K, Nishio Y, Sugaya T, Kashiwagi A, Okamura T . Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension. 2003; 43(2):255-62. DOI: 10.1161/01.HYP.0000111136.86976.26. View

18.

Naghavi M, Libby P, Falk E, Casscells S, Litovsky S, Rumberger J . From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003; 108(14):1664-72. DOI: 10.1161/01.CIR.0000087480.94275.97. View

19.

Li M, Payne T, Ma J, Lou X, Zhang D, Dupont R . A genomewide search finds major susceptibility loci for nicotine dependence on chromosome 10 in African Americans. Am J Hum Genet. 2006; 79(4):745-51. PMC: 1592559. DOI: 10.1086/508208. View

20.

Eitzman D, Westrick R, Shen Y, Bodary P, Gu S, Manning S . Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice. Circulation. 2005; 111(14):1822-5. DOI: 10.1161/01.CIR.0000160854.75779.E8. View